CompletedNot Applicable

The Efficacy of Hyperemesis Gravidarum on Macular Thickness, Corneal Thickness and Intraocular Pressure in Pregnancy

Turkey (Türkiye)110 participantsStarted 2020-03-10

Plain-language summary

Aim Physiological changes in intraocular pressure as well as in the cornea and macula may occur during pregnancy. In the literature, there are limited data on ocular findings in hyperemesis gravidarum. Therefore, we have decided to investigate the effect of hyperemesis gravidarum on macular thickness, corneal thickness and intraocular pressure (IOP).

Who can participate

Age range18 Years – 40 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Inclusion criteria for the study; * First trimester (8-14 weeks of gestation) pregnancy with positive fetal heartbeat and no history of systemic disease , * no history of continuous drug use, * Diagnosis of hyperemesis gravidarum (ketonuria and weight \>3 kg or 5% of the body) The occurrence of \>3 vomiting attacks per day with loss of weight, * Body mass index (BMI) within normal limits, * Being between the ages of 18-40 , * not drinking alcohol or smoking, * not using any vitamins or supplements use during the study Exclusion Criteria: * Any patient who did not meet the inclusion criteria was excluded from the study. * Patients who participated in the study but later gave up

What they're measuring

Take precautions of the effect of hyperemesis gravidarum on eye health

Timeframe: Healthy pregnant women and pregnant women diagnosed with Hyperemesis gravidarum between 6-14 weeks; eye examination findings were immediately recorded in the system. (within 1 day)

Trial details

NCT IDNCT05927740

SponsorBatman Training and Research Hospital

Sponsor typeOTHER_GOV

Study typeINTERVENTIONAL

Primary completion2022-02-13

View on ClinicalTrials.gov More Corneal Dystrophy trials